Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Denton

Showing results (471-480 of 607) with videos related to

Pageof 61
Sort By:
The Lancet. Rheumatology|January 24, 2022
Systemic sclerosis and COVID-19 vaccines: a SPIN Cohort studyJessica K Gordon, Kimberly Showalter, Yin Wu, et al.
Rheumatology (Oxford, England)|October 17, 2024
Deep-learning CT imaging algorithm to detect usual interstitial pneumonia pattern in patients with systemic sclerosis-associated interstitial lung disease: association with disease progression and survivalCarmel J W Stock, Yang Nan, Yingying Fang, et al.
Arthritis Research & Therapy|January 27, 2011
mPGES-1 null mice are resistant to bleomycin-induced skin fibrosisMatthew R McCann, Roxana Monemdjou, Parisa Ghassemi-Kakroodi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 8, 2019
Reduced Right Ventricular Output Reserve in Patients With Systemic Sclerosis and Mildly Elevated Pulmonary Artery PressureChristian Nagel, Alberto M Marra, Nicola Benjamin, et al.
Rheumatology (Oxford, England)|February 17, 2022
Nailfold capillaroscopy in SSc: innocent bystander or promising biomarker for novel severe organ involvement/progression?Amber Vanhaecke, Maurizio Cutolo, Oliver Distler, et al.
Annals of the Rheumatic Diseases|May 21, 2013
Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT studyJ Gerry Coghlan, Christopher P Denton, Ekkehard Grünig, et al.
The Journal of Rheumatology|March 17, 2020
Analysis of Anti-RNA Polymerase III Antibody-positive Systemic Sclerosis and Altered GPATCH2L and CTNND2 Expression in Scleroderma Renal CrisisEdward P Stern, Sandra G Guerra, Harry Chinque, et al.
The Lancet. Respiratory Medicine|September 1, 2020
Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trialDinesh Khanna, Celia J F Lin, Daniel E Furst, et al.
The Journal of Biological Chemistry|February 15, 2005
Activation of key profibrotic mechanisms in transgenic fibroblasts expressing kinase-deficient type II Transforming growth factor-{beta} receptor (T{beta}RII{delta}k)Christopher P Denton, Gisela E Lindahl, Korsa Khan, et al.
The Journal of Rheumatology|October 4, 2011
Analysis of the validation status of quality of life and functional disability measures in pulmonary arterial hypertension related to systemic sclerosis: results of a systematic literature analysis by the Expert Panel on Outcomes Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS)Otylia Kowal-Bielecka, Jerome Avouac, David Pittrow, et al.
Pageof 61

Showing results (471-480 of 607) with videos related to

Sort By:
Pageof 61
The Lancet. Rheumatology|January 24, 2022
Systemic sclerosis and COVID-19 vaccines: a SPIN Cohort studyJessica K Gordon, Kimberly Showalter, Yin Wu, et al.
Rheumatology (Oxford, England)|October 17, 2024
Deep-learning CT imaging algorithm to detect usual interstitial pneumonia pattern in patients with systemic sclerosis-associated interstitial lung disease: association with disease progression and survivalCarmel J W Stock, Yang Nan, Yingying Fang, et al.
Arthritis Research & Therapy|January 27, 2011
mPGES-1 null mice are resistant to bleomycin-induced skin fibrosisMatthew R McCann, Roxana Monemdjou, Parisa Ghassemi-Kakroodi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 8, 2019
Reduced Right Ventricular Output Reserve in Patients With Systemic Sclerosis and Mildly Elevated Pulmonary Artery PressureChristian Nagel, Alberto M Marra, Nicola Benjamin, et al.
Rheumatology (Oxford, England)|February 17, 2022
Nailfold capillaroscopy in SSc: innocent bystander or promising biomarker for novel severe organ involvement/progression?Amber Vanhaecke, Maurizio Cutolo, Oliver Distler, et al.
Annals of the Rheumatic Diseases|May 21, 2013
Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT studyJ Gerry Coghlan, Christopher P Denton, Ekkehard Grünig, et al.
The Journal of Rheumatology|March 17, 2020
Analysis of Anti-RNA Polymerase III Antibody-positive Systemic Sclerosis and Altered GPATCH2L and CTNND2 Expression in Scleroderma Renal CrisisEdward P Stern, Sandra G Guerra, Harry Chinque, et al.
The Lancet. Respiratory Medicine|September 1, 2020
Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trialDinesh Khanna, Celia J F Lin, Daniel E Furst, et al.
The Journal of Biological Chemistry|February 15, 2005
Activation of key profibrotic mechanisms in transgenic fibroblasts expressing kinase-deficient type II Transforming growth factor-{beta} receptor (T{beta}RII{delta}k)Christopher P Denton, Gisela E Lindahl, Korsa Khan, et al.
The Journal of Rheumatology|October 4, 2011
Analysis of the validation status of quality of life and functional disability measures in pulmonary arterial hypertension related to systemic sclerosis: results of a systematic literature analysis by the Expert Panel on Outcomes Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS)Otylia Kowal-Bielecka, Jerome Avouac, David Pittrow, et al.
Pageof 61